FDA takes steps to bring diagnostics to patients faster

FDA Commissioner Scott Gottlieb highlighted steps the agency is taking to speed patient access to new medical devices, such as diagnostics, and laid out its framework for review of premarket approval applications (PMAs). Gottlieb unveiled the plans in remarks at

Read the full 400 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE